Compare IGC & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IGC | PRT |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7M | 29.6M |
| IPO Year | 2005 | N/A |
| Metric | IGC | PRT |
|---|---|---|
| Price | $0.26 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 323.5K | 36.8K |
| Earning Date | 03-19-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | ★ 59.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,271,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $1.82 |
| 52 Week High | $0.50 | $4.14 |
| Indicator | IGC | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 44.70 |
| Support Level | $0.25 | $2.03 |
| Resistance Level | $0.31 | $2.39 |
| Average True Range (ATR) | 0.01 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 6.20 | 31.82 |
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.